Older cancer survivors typically have higher severity of disease and pre-existing conditions, which makes their cancer treatment additionally challenging. The Patient Care Connect Program was created to help address these issues.
Older adults are underrepresented in clinical trials of cancer drugs, according to study findings presented at the 2017 ASCO Annual Meeting.
Children and adolescent patients with cancer are able to accurately report subjective adverse events (AEs) they experience during their cancer treatment, and they are willing to do so.
The medications so far show little efficacy in children with cancer, but new studies may provide clues to how to change this, pediatric oncologist says.
Small study also showed that pembrolizumab does not significant impair radiation or chemotherapy dosing.
Ovarian function recovery (OFR) in women with chemotherapy-induced ovarian function failure decreases residual 5-year disease-free and overall survival.
Study also provides evidence supporting an anti-tumor effect associated with a single preoperative dose of pembrolizumab.
Patients aged 80 years and older had a cancer incidence of 16% in 2013 yet made up only 4% of cancer drug clinical trial participants during 2005-2015.
Some men who undergo multigene testing for inherited prostate cancer misinterpret findings of variants of uncertain significance.
Study finds a correlation between various measures of neurocognitive function and health utility scores.
Please login or register first to view this content.
